Last updated at 29 Jun 2024 11:21 AM
Director
DIN: 00842857
Anil Kumar Sharma is currently associated with 2 companies in various capacities such as Managing Director and Additional Director. They serve as a Director at ULTRAMED PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00842857.Anil Kumar Sharma has previously been associated with 1 company in roles such as Director.Anil Kumar Sharma is currently involved in 2 different roles. Their most recent position is with BIOSOFTRONICS PRIVATE LIMITED as a Additional Director. The first company Anil Kumar Sharma was appointed to was ULTRAMED PRIVATE LIMITED. Anil Kumar Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Anil Kumar Sharma is currently associated with 2 companies in various capacities such as Managing Director and Additional Director. They serve as a Director at ULTRAMED PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00842857.Anil Kumar Sharma has previously been associated with 1 company in roles such as Director.Anil Kumar Sharma is currently involved in 2 different roles. Their most recent position is with BIOSOFTRONICS PRIVATE LIMITED as a Additional Director. The first company Anil Kumar Sharma was appointed to was ULTRAMED PRIVATE LIMITED. Anil Kumar Sharma is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
7y 10m 3y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ULTRAMED PRIVATE LIMITED | Managing Director | 11-Dec-1986 |
| BIOSOFTRONICS PRIVATE LIMITED | Additional Director | 04-Apr-2023 |